Corrigendum to "SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type" [Leukemia Res. 96 (2020) 106422]

Leuk Res. 2020 Dec:99:106446. doi: 10.1016/j.leukres.2020.106446. Epub 2020 Sep 24.
No abstract available

Publication types

  • Published Erratum